3-((3,4-Difluorophenyl)thio)-2-hydroxy-2-methyl-N-(4-nitro-2-(trifluoromethyl)phenyl)propanamide

ID: ALA4549796

PubChem CID: 155550281

Max Phase: Preclinical

Molecular Formula: C17H13F5N2O4S

Molecular Weight: 436.36

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(O)(CSc1ccc(F)c(F)c1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F

Standard InChI:  InChI=1S/C17H13F5N2O4S/c1-16(26,8-29-10-3-4-12(18)13(19)7-10)15(25)23-14-5-2-9(24(27)28)6-11(14)17(20,21)22/h2-7,26H,8H2,1H3,(H,23,25)

Standard InChI Key:  JGEITDDJBCVTLM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 30  0  0  0  0  0  0  0  0999 V2000
   15.8343  -20.4053    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   19.4122  -19.1719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4111  -19.9994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1259  -20.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8424  -19.9989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8396  -19.1682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1242  -18.7592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6963  -20.4113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9821  -19.9983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2671  -20.4102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9827  -19.1732    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5530  -19.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6760  -20.9929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8469  -20.9929    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1239  -19.9959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1242  -19.1781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4148  -18.7687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7041  -19.1793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7073  -20.0033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4174  -20.4090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1257  -21.2373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4111  -21.6497    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.8401  -21.6500    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.1179  -22.0596    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.5547  -18.7517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5515  -17.9266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.2707  -19.1616    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.9946  -20.4189    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.9888  -18.7681    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  2  2  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 12  1  1  0
 10 13  1  0
 10 14  1  0
  1 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  4 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
 25 26  2  0
 25 27  1  0
  6 25  1  0
 19 28  1  0
 18 29  1  0
M  CHG  2  25   1  27  -1
M  END

Alternative Forms

  1. Parent:

    ALA4549796

    ---

Associated Targets(Human)

CWR22R (2180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VCaP (1078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 436.36Molecular Weight (Monoisotopic): 436.0516AlogP: 4.37#Rotatable Bonds: 6
Polar Surface Area: 92.47Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.14CX Basic pKa: CX LogP: 4.31CX LogD: 4.31
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.30Np Likeness Score: -1.67

References

1. Bassetto M, Ferla S, Pertusati F, Kandil S, Westwell AD, Brancale A, McGuigan C..  (2016)  Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer.,  118  [PMID:27131065] [10.1016/j.ejmech.2016.04.052]

Source